Sarana Meditama Metropolitan Total Liabilities
Sarana Meditama Metropolitan total liabilities. Based on the latest financial reports, Sarana Meditama Metropolitan (SAME) has total liabilities worth Rp1.51 Trillion IDR (≈ $88.63 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Sarana Meditama Metropolitan liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Sarana Meditama Metropolitan (2009–2025)
Total liabilities of Sarana Meditama Metropolitan from 2009 to 2025. This chart illustrates how Sarana Meditama Metropolitan's total liabilities have evolved over time, based on quarterly financial data.
Sarana Meditama Metropolitan Competitors by Total Liabilities
The table below lists competitors of Sarana Meditama Metropolitan ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Pss Co Ltd
TW:6914
|
Taiwan | NT$6.63 Billion |
|
Egis Technology
TWO:6462
|
Taiwan | NT$5.77 Billion |
|
RF Capital Group Inc
TO:RCG
|
Canada | CA$1.06 Billion |
|
AstroNova Inc
NASDAQ:ALOT
|
USA | $62.23 Million |
|
Nam Kim Steel JSC
VN:NKG
|
Vietnam | ₫8.39 Trillion |
|
Dateline Resources Ltd
AU:DTR
|
Australia | AU$3.11 Million |
|
Copper Fox Metals Inc.
V:CUU
|
Canada | CA$1.22 Million |
|
Bioteque
TWO:4107
|
Taiwan | NT$1.35 Billion |
Liability Composition Analysis (2009–2025)
This chart breaks down Sarana Meditama Metropolitan's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Sarana Meditama Metropolitan asset portfolio.
Liquidity & Leverage Metrics
Sarana Meditama Metropolitan Total Liabilities Ratios Explained
Sarana Meditama Metropolitan total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.42 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.40 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sarana Meditama Metropolitan's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sarana Meditama Metropolitan (2009–2025)
The table below shows the annual total liabilities of Sarana Meditama Metropolitan from 2009 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Rp1.64 Trillion ≈ $95.89 Million |
+15.24% |
| 2024-12-31 | Rp1.42 Trillion ≈ $83.21 Million |
+2.82% |
| 2023-12-31 | Rp1.38 Trillion ≈ $80.93 Million |
+19.38% |
| 2022-12-31 | Rp1.16 Trillion ≈ $67.79 Million |
+123.76% |
| 2021-12-31 | Rp517.06 Billion ≈ $30.30 Million |
-61.52% |
| 2020-12-31 | Rp1.34 Trillion ≈ $78.74 Million |
+7.04% |
| 2019-12-31 | Rp1.26 Trillion ≈ $73.56 Million |
+4.36% |
| 2018-12-31 | Rp1.20 Trillion ≈ $70.49 Million |
+78.89% |
| 2017-12-31 | Rp672.45 Billion ≈ $39.40 Million |
+11.90% |
| 2016-12-31 | Rp600.93 Billion ≈ $35.21 Million |
+30.06% |
| 2015-12-31 | Rp462.04 Billion ≈ $27.07 Million |
+67.66% |
| 2014-12-31 | Rp275.58 Billion ≈ $16.15 Million |
+12.65% |
| 2013-12-31 | Rp244.64 Billion ≈ $14.34 Million |
-9.91% |
| 2012-12-31 | Rp271.56 Billion ≈ $15.91 Million |
-11.52% |
| 2011-12-31 | Rp306.90 Billion ≈ $17.98 Million |
-1.71% |
| 2010-12-31 | Rp312.24 Billion ≈ $18.30 Million |
+7.04% |
| 2009-12-31 | Rp291.70 Billion ≈ $17.09 Million |
-- |
About Sarana Meditama Metropolitan
PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. The company operates specialty centers. It also is involved in trading of medical equipment; healthcare pharmacy; real estate; and agriculture. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Ma… Read more